Effect of treatment with L0006CP on the time of fracture-healing

ISRCTN ISRCTN71678602
DOI https://doi.org/10.1186/ISRCTN71678602
EudraCT/CTIS number 2010-020973-18
Secondary identifying numbers 2010-020973-18
Submission date
23/02/2011
Registration date
07/04/2011
Last edited
20/05/2019
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Injury, Occupational Diseases, Poisoning
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Stanislaw Pomianowskip
Scientific

Klinika Chirurgii Urazowej Narządu Ruchu i Ortopedii CMKP Samodzielny Publiczny Szpital Kliniczny
im. Prof. Adama Grucy
ul. Konarskiego 13
Otwock
05-400
Poland

Study information

Study designProspective multicentre double-blind randomised placebo controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleEffect of treatment with L0006CP on the time of fracture-healing: a prospective, multi-centre, double-blind, randomised, placebo controlled clinical trial
Study acronymL0006CP
Study objectivesTo compare the effect of a treatment with ossein L0006CP compound versus a placebo on the time of fracture-healing in patients with a wrist fracture
Ethics approval(s)Not provided at time of registration.
Bioethical committee of Centre for Medical Education, Warsaw (Centrum Medyczne Kształcenia) - approval pending
Health condition(s) or problem(s) studiedWrist fracture
InterventionL0006CP film-coated tablets OR placebo tablets for 12 weeks (1 tablet twice a day)
Intervention typeOther
Primary outcome measureComparison between the two treatments, of the time to radiological healing in the two groups
Secondary outcome measuresComparison between the two groups of:
1. Time to disappearance of fracture line
2. Time to full normal activity of daily living involving the target upper limb
3. Percentage of patients with at least one adverse event occurring under treatment
Overall study start date15/03/2011
Completion date15/10/2011

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants90
Total final enrolment58
Key inclusion criteria1. Male or menopausal female between 50 and 80 years of age
2. A recent closed Colles fracture, correctly reduced and stabilised
3. Willing, able to understand and sign an approved informed consent form
4. Able to understand the protocol and to come to the control visits
Key exclusion criteria1. Fractures not meeting inclusion criteria (including pathological fractures)
2. Previous or concomitant treatment that may influence recovery
3. Concomittant treatments interfering with bone metabolism
Date of first enrolment15/03/2011
Date of final enrolment15/10/2011

Locations

Countries of recruitment

  • Poland

Study participating centre

Klinika Chirurgii Urazowej Narządu Ruchu i Ortopedii CMKP Samodzielny Publiczny Szpital Kliniczny
Otwock
05-400
Poland

Sponsor information

Pierre Fabre (France)
Industry

Canceropole
3 Avenue Hubert Curien
BP13562
Toulouse Cedex
31035
France

ROR logo "ROR" https://ror.org/04hdhz511

Funders

Funder type

Industry

Pierre Fabre (France)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Basic results 20/05/2019 No No

Editorial Notes

The following changes were made to the trial record:
1. Added clinicaltrialsregister.eu link to basic results (scientific).
2. The total final enrollment was added.